MaxCyte - Stock Price History | MXCT

Historical daily share price chart and data for MaxCyte since 2021 adjusted for splits. The latest closing stock price for MaxCyte as of October 15, 2021 is 11.03.
  • The all-time high MaxCyte stock closing price was 17.20 on September 03, 2021.
  • The MaxCyte 52-week high stock price is 17.44, which is 58.1% above the current share price.
  • The MaxCyte 52-week low stock price is 9.45, which is 14.3% below the current share price.
  • The average MaxCyte stock price for the last 52 weeks is 14.25.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
MaxCyte Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $1.139B $0.026B
MaxCyte Inc. is a provider of cell-engineering enabling technology and is responsible cell-based therapies. MaxCyte Inc. is headquartered in Gaithersburg, Maryland.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $128.216B 8.54
Bio-Rad Laboratories (BIO.B) United States $21.975B 46.83
QIAGEN (QGEN) Netherlands $11.812B 20.00
Biohaven Pharmaceutical Holding (BHVN) United States $8.815B 0.00
Emergent Biosolutions (EBS) United States $2.763B 6.66
Arcus Biosciences (RCUS) United States $2.321B 0.00
Myovant Sciences (MYOV) United Kingdom $1.993B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.769B 0.00
Zymeworks (ZYME) Canada $1.152B 0.00
Ambrx Biopharma (AMAM) United States $0.431B 0.00
SQZ Biotechnologies (SQZ) United States $0.346B 0.00
Enzo Biochem (ENZ) United States $0.188B 18.43